A measuring device, filtering method, manufacturing method and production device for particles in liquid medicine for semiconductor manufacturing

By setting branch points and merging points in the detection device of the semiconductor manufacturing drug liquid, using the difference in specific gravity of bubbles, combined with the liquid ejector and filter, the bubble interference problem is solved, the measurement accuracy is improved, and the quality of the drug liquid is ensured.

CN118501005BActive Publication Date: 2024-12-06FUJIFILM ELECTRONICS MATERIALS SUZHOU
View PDF 15 Cites 0 Cited by

Patent Information

Application Number
CN202410928687.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-11
Publication Date
2024-12-06
Estimated Expiration
2044-07-11

AI Technical Summary

Technical Problem

When the existing liquid microparticle detection device detects microparticles in the semiconductor manufacturing liquid, it is susceptible to bubble interference, resulting in a decrease in measurement accuracy and fails to effectively solve this problem.

Method used

A device including a liquid tank, a flow path system and a measuring device is designed. By setting branch points and confluence points in the flow path system, the specific gravity of the bubbles is smaller than that of the liquid, and the measuring device is set below to reduce the bubbles entering the measurement area, and The liquid circulation and filtration are realized through the liquid sprayer and filter to ensure measurement accuracy.

Benefits of technology

It effectively reduces the impact of bubbles on measurement accuracy, improves the accuracy of measuring the number of particles in the drug solution, and ensures the quality of the drug solution during semiconductor manufacturing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118501005B_ABST
    Figure CN118501005B_ABST
Patent Text Reader

Abstract

A device for measuring particles in a liquid medicine for semiconductor manufacturing, a filtering method, a manufacturing method and a production device, the device comprising a liquid tank, a first flow path, a second flow path extending from a branch point of the first flow path to a confluence point on the downstream side, a liquid ejector arranged on the upstream side of the branch point, a filter arranged between the liquid ejector and the branch point, and a measuring device for counting the number of particles contained in the liquid medicine in the second flow path. A descending portion extending from the branch point and descending in the vertical direction as it moves toward the downstream side is provided in the second flow path. In the first flow path, the flow path adjacent to the branch point on the upstream side of the branch point and the flow path adjacent to the branch point on the downstream side of the branch point are arranged in a straight line; the cross-sectional area of ​​the flow path adjacent to the branch point on the upstream side of the branch point in the first orthogonal direction orthogonal to the direction in which the first flow path extends is the same as the cross-sectional area of ​​the flow path adjacent to the branch point on the downstream side of the branch point in the first orthogonal direction.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a measuring device, a filtering method, a manufacturing method and a production device for particles in a chemical solution for semiconductor manufacturing used in the manufacture of semiconductor elements, etc., and in particular to a measuring device, a filtering method, a manufacturing method and a production device for particles in a chemical solution for semiconductor manufacturing that measure the number of particles contained in the chemical solution for semiconductor manufacturing. Background Art

[0002] In order to form semiconductor elements such as IC (Integrated Circuit) and LSI (Large Scale Integrated Circuit), a resist as a liquid medicine is sprayed onto a semiconductor wafer to form a resist film on the semiconductor wafer. Then, the resist film is exposed and developed to form a pattern portion. Then, etching is performed to form a pattern on the semiconductor wafer. In addition, CMP (chemical mechanical polishing) is also performed to flatten the semiconductor wafer. After the above-mentioned etching and CMP are performed, the semiconductor wafer is cleaned with a liquid medicine.

[0003] Various chemical solutions are used in the manufacture of semiconductor elements, etc. If the resist contains particles, it will cause defects in the resist film. In addition, when the chemical solution is used for cleaning, a sufficient cleaning effect cannot be obtained. Therefore, it is necessary to measure the particles contained in the chemical solution.

[0004] For example, Japanese Patent Gazette No. 9-05228 describes a device for detecting particles in liquid, which detects particles contained in liquid. The device for detecting particles in liquid comprises: a liquid supply pipe, which allows liquid to flow; a light scattering particle detection unit, which is arranged in the liquid supply pipe; and a calculation unit, which calculates the number of particles per unit flow contained in the liquid based on a detection signal from the particle detection unit and the flow rate of the liquid.

[0005] When the liquid microparticle detection device of the patent document is used to detect microparticles in liquid, if there are bubbles in the liquid, the bubbles may be measured (counted) as particles. In this case, the measured value of the microparticles also includes the number of bubbles, resulting in reduced measurement accuracy.

[0006] However, in the liquid microparticle detection device of this patent document, no consideration is given to air bubbles which may cause a decrease in measurement accuracy.

[0007] In view of this, those skilled in the art need to improve the existing detection device to reduce the influence of bubbles on the measurement accuracy during detection. Summary of the invention

[0008] The main purpose of the present application is to provide a measuring device, a filtering method, a manufacturing method and a production device for particles in a chemical solution used in semiconductor manufacturing, so as to reduce the influence of bubbles on the measurement accuracy during detection.

[0009] In order to achieve the above-mentioned purpose, in a first aspect, the present application provides a device for measuring particles in a liquid medicine for semiconductor manufacturing, comprising:

[0010] A liquid tank for storing chemical solutions used in semiconductor manufacturing;

[0011] The liquid tank has an outflow end for the liquid medicine to flow out of the liquid tank and an inflow end for the liquid medicine to flow into the liquid tank;

[0012] A first flow path connecting the outflow end and the inflow end for the liquid medicine to flow;

[0013] a second flow path extending from a branch point in the first flow path to a confluence point in the first flow path located downstream of the branch point;

[0014] a liquid ejector disposed in the first flow path on the upstream side of the branch point and causing the liquid medicine in the liquid tank to flow into the first flow path;

[0015] a filter disposed between the liquid ejector and the branch point in the first flow path; and

[0016] a measuring device disposed in the second flow path and configured to count the number of particles contained in the drug solution in the second flow path;

[0017] The second flow path includes a descending portion extending from the branch point and descending in the vertical direction toward the downstream side thereof.

[0018] In the first flow path, a flow path adjacent to the branch point on the upstream side of the branch point and a flow path adjacent to the branch point on the downstream side of the branch point are arranged in a straight line,

[0019] In the first flow path, the cross-sectional area of ​​the flow path adjacent to the branch point on the upstream side of the branch point in a first orthogonal direction perpendicular to the direction in which the first flow path extends is the same as the cross-sectional area of ​​the flow path adjacent to the branch point on the downstream side of the branch point in the first orthogonal direction.

[0020] A further improvement is that, in the first flow path, the cross-sectional area of ​​the flow path adjacent to the branch point on the upstream side of the branch point in the first orthogonal direction, and the cross-sectional area of ​​the flow path adjacent to the branch point on the downstream side of the branch point in the first orthogonal direction are larger than the cross-sectional area of ​​the second flow path in the second orthogonal direction orthogonal to the direction in which the second flow path extends.

[0021] As a further improvement, in the first flow path, the cross-sectional area in the first orthogonal direction is constant within the range from the flow path adjacent to the branch point on the upstream side of the branch point to the flow path adjacent to the confluence point on the downstream side of the confluence point.

[0022] A further improvement is that the extending direction of the descending portion is inclined by more than 45° relative to the horizontal plane.

[0023] A further improvement is that, in the vertical direction, the confluence point is located above the branch point, and the direction in which the first flow path extends is inclined at more than 45° from the branch point relative to the horizontal plane.

[0024] A further improvement is that the direction in which the first flow path extends is inclined by more than 85° relative to the horizontal plane from the branch point.

[0025] As a further improvement, a rising portion is provided in the second flow path, which extends toward the confluence point to the confluence point and rises in the vertical direction toward the downstream side.

[0026] A further improvement is that the extending direction of the rising portion is inclined by more than 45° relative to the horizontal plane.

[0027] A further improvement is that the liquid medicine is a cleaning liquid.

[0028] A further improvement is that the chemical solution is a cleaning solution used in cleaning performed after chemical mechanical polishing.

[0029] A further improvement is that the drug solution contains carboxylic acid and phosphonic acid.

[0030] A further improvement is that the drug solution is obtained by mixing two or more raw materials in the liquid tank.

[0031] In order to achieve the above-mentioned purpose, in a second aspect, the present application provides a device for producing a chemical solution for semiconductor manufacturing, comprising the above-mentioned measuring device.

[0032] In order to achieve the above-mentioned purpose, in a third aspect, the present application provides a method for filtering a chemical solution for semiconductor manufacturing, comprising a step of filtering the chemical solution using the above-mentioned measuring device.

[0033] In order to achieve the above-mentioned purpose, in a fourth aspect, the present application provides a method for manufacturing a chemical solution for semiconductor manufacturing, which has a step of using the above-mentioned measuring device to mix two or more raw materials to manufacture the chemical solution.

[0034] The present invention provides a measuring device, filtering method, manufacturing method and production device for particles in a liquid medicine for semiconductor manufacturing. Compared with the prior art, the second flow path provided with a measuring device is arranged below the first flow path. Since the specific gravity of bubbles is less than that of liquid, bubbles generated during detection are not easy to enter the second flow path, thereby reducing the impact of bubbles on reduced detection accuracy during detection; in addition, the second flow path can also be arranged at an upward lifting position of the first flow path. During the liquid circulation process, bubbles rise with the liquid, thereby reducing bubbles entering the second flow path from the branch point, and also ensuring the detection accuracy. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] The drawings constituting a part of this application are used to provide a further understanding of this application, so that other features, purposes and advantages of this application become more obvious. The schematic embodiment drawings and their descriptions of this application are used to explain this application and do not constitute an improper limitation on this application. In the drawings:

[0036] Figure 1 is a schematic diagram of a first example of a particle measuring device in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0037] Figure 2 It is a schematic diagram of the main parts of a first example of a particle measuring device in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0038] Figure 3 It is a schematic diagram of the arrangement of the first flow path and the second flow path in the first example of the device for measuring particles in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0039] Figure 4 is a schematic diagram of a second example of a particle measuring device in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0040] Figure 5 It is a schematic diagram of the main part of a second example of the particle measuring device in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0041] Figure 6 It is a schematic diagram of the arrangement of the first flow path and the second flow path in the second example of the device for measuring particles in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0042] Figure 7is a schematic diagram of a third example of a particle measuring device in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0043] Figure 8 It is a schematic diagram of the main part of a third example of the particle measuring device in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention;

[0044] Fig. 9 It is a schematic diagram of a modification of the main part of the third example of the particle measuring device in a chemical solution for semiconductor manufacturing according to the embodiment of the present invention;

[0045] Fig.10 is a schematic diagram of the configuration of the first flow path and the second flow path in Comparative Example 1;

[0046] Fig.11 is a schematic diagram of the configuration of the first flow path and the second flow path in Comparative Example 2;

[0047] Fig.12 Schematic diagram of the arrangement of the first flow path and the second flow path in Comparative Example 3.

[0048] Among them: 10, 10a, 10b: a measuring device for particles in a liquid used in semiconductor manufacturing; 12: a liquid tank; 14: a first flow path; 14b, 14c, 14d, 14f: a flow path; 15: a first pipe; 15b, 17a: a first pipe; 15c, 17b: a second pipe; 15d: a third pipe; 15e: a curved portion; 16: a second flow path; 16a: a descending portion; 16b: an ascending portion; 16c: a connecting portion; 17: a second pipe; 17c: a connecting pipe; 18: a liquid ejector; 20: a filter; 22: a measuring device; 24: a discharge flow path; 24a: a straight portion; 24b: Bending portion; 25: discharge piping; 25a: straight pipe portion; 25b: bending pipe portion; 26: valve; 27: control portion; 28: container; 29: raw material supply portion; 30: first tank; 31a, 33a, 35a: piping; 31b, 33b, 35b: pump; 31c, 33c, 35c: valve; 32: second tank; 34: third tank. DETAILED DESCRIPTION

[0049] Hereinafter, a measuring device for particles in a chemical solution for semiconductor manufacturing, a filtering method, a manufacturing method, and a production device of the present invention will be described in detail based on the preferred embodiments shown in the drawings.

[0050] In addition, the following drawings are used to illustrate a device for measuring particles in a chemical solution used for semiconductor manufacturing, but the structure of the device for measuring particles in a chemical solution used for semiconductor manufacturing shown below is simplified for the purpose of illustrating the present invention, and the present invention is not limited to the structure of the drawings shown below.

[0051] Hereinafter, "to" indicating a numerical range includes the numerical values ​​described on both sides. For example, the so-called ε is a numerical value εα to a numerical value εβ, which means that the range of ε is a range including the numerical values ​​εα and εβ, and if expressed in mathematical symbols, it is εα≤ε≤εβ.

[0052] In addition, as for specific angles, parallelism and orthogonality, unless otherwise specified, they are included in the error range generally allowed in the corresponding technical field. Also, as for length and temperature, unless otherwise specified, they are included in the error range generally allowed in the corresponding technical field.

[0053] The first example of a device for measuring particles in chemical solutions used in semiconductor manufacturing

[0054] Figure 1 This is a schematic diagram showing a first example of a particle measuring device in a chemical solution used in semiconductor manufacturing according to an embodiment of the present invention. Figure 2 This is a schematic diagram showing the main parts of a first example of a particle measuring device in a chemical solution used for semiconductor manufacturing according to an embodiment of the present invention. Figure 3 This is a schematic diagram showing the arrangement of the first flow path and the second flow path in the first example of the device for measuring particles in a chemical solution for semiconductor manufacturing according to an embodiment of the present invention.

[0055] Figure 1 The device 10 for measuring particles in a semiconductor manufacturing chemical solution is an example of a device for measuring particles in a semiconductor manufacturing chemical solution. The device 10 for measuring particles in a semiconductor manufacturing chemical solution measures the number of particles in the chemical solution during the process of manufacturing the semiconductor manufacturing chemical solution.

[0056] The device 10 for measuring particles in a chemical solution used in semiconductor manufacturing includes a liquid tank 12 , a first flow path 14 , a second flow path 16 , a liquid ejector 18 , a filter 20 , a measuring device 22 , a discharge flow path 24 , a valve 26 , a control unit 27 , and a container 28 .

[0057] The liquid tank 12 is a component for storing chemical liquid (not shown) for semiconductor manufacturing. The size, capacity, structure and material of the liquid tank 12 are not particularly limited as long as it can store the chemical liquid as described above, and a liquid tank corresponding to the composition and amount of the chemical liquid can be used appropriately.

[0058] The liquid tank 12 includes an outflow end Pd through which the chemical solution flows out of the liquid tank 12 , and an inflow end Pe through which the chemical solution flows into the liquid tank 12 .

[0059] The first flow path 14 is a flow path that connects the outflow end Pd and the inflow end Pe of the liquid tank 12 and allows the drug solution to flow. The drug solution discharged from the outflow end Pd of the liquid tank 12 returns to the liquid tank 12 through the first flow path 14 and flows into the liquid tank 12 again from the inflow end Pe. That is, the drug solution in the liquid tank 12 circulates through the first flow path 14. Figure 1 In the embodiment, the first flow path 14 is configured in a quadrilateral shape, having a straight flow path and four bends. The bend angle of the bend is, for example, 90°. Although the straight flow paths are arranged relative to each other, the extending directions of the two straight flow paths relative to each other are parallel.

[0060] The first flow path 14 is constituted by, for example, a first pipe 15. Strictly speaking, the internal space of the first pipe 15 forms the first flow path 14. The first pipe 15 has a straight pipe portion and four bent pipe portions (bends) constituting a linear flow path, similarly to the first flow path 14. The bending angle of the bent pipe portion is, for example, 90°. In the first pipe 15, the extending directions of the straight pipe portions opposite to each other are parallel. For example, in the first pipe 15, the cross-sectional shape in the direction orthogonal to the extending direction thereof is circular. In addition, in the first flow path 14, the cross-sectional shape orthogonal to the extending direction thereof is also circular.

[0061] The first pipe 15 is connected to the outflow end Pd and the inflow end Pe of the liquid tank 12 .

[0062] In addition, in the first flow path 14, the side close to the outflow end Pd of the liquid tank 12 is set as the upstream side, and the side close to the inflow end Pe is set as the downstream side.

[0063] The first flow path 14 is not particularly limited to being arranged in a rectangular shape as long as it can circulate the drug solution in the liquid tank 12. The first flow path 14 may be arranged in a circular ring shape, for example. That is, the laying path of the first flow path 14 can be determined arbitrarily.

[0064] The second flow path 16 is a flow path extending from the branch point Pj in the first flow path 14 to the confluence point Pc located downstream of the branch point Pj in the first flow path 14. In the second flow path 16, the branch point Pj side is the downstream side, and the confluence point Pc side is the upstream side.

[0065] like Figure 2 As shown, the second flow path 16 has a descending portion 16a extending from the branch point Pj and descending toward the downstream side in the vertical direction Z. In addition, the second flow path 16 has an ascending portion 16b extending toward the confluence point Pc and ascending toward the downstream side in the vertical direction Z.

[0066] In addition, a measuring device 22 is arranged at a midway position of the second flow path 16. The descending portion 16a is connected to the liquid medicine inlet Pi of the measuring device 22 via a connecting portion 16c, and the ascending portion 16b is connected to the liquid medicine outlet Po via a connecting portion 16c. The direction in which the connecting portion 16c extends is parallel to the extending direction DL in which the first flow path 14 provided with the second flow path 16 extends. However, the extending direction of the connecting portion 16c is not particularly limited, and may be inclined relative to the extending direction of the first flow path 14 provided with the second flow path 16.

[0067] The second flow path 16 is constituted by the second pipe 17. Strictly speaking, the internal space of the second pipe 17 forms the second flow path 16. The second pipe 17 is connected to a position corresponding to the branch point Pj of the first pipe 15 and a position corresponding to the confluence point Pc of the first pipe 15, respectively.

[0068] In addition, the second piping 17 includes a first pipe 17a corresponding to the descending portion 16a of the second flow path 16, a second pipe 17b corresponding to the ascending portion 16b, and a connecting pipe 17c corresponding to the connecting portion 16c. The first pipe 17a is connected to the drug liquid inlet Pi of the measuring device 22 via the connecting pipe 17c, and the second pipe 17b is connected to the drug liquid outlet Po via the connecting pipe 17c. The direction in which the connecting pipe 17c extends is parallel to the direction in which the first piping 15 provided with the second piping 17 extends. However, the extending direction of the connecting pipe 17c is not particularly limited, and may be inclined relative to the extending direction of the first piping 15 provided with the second piping 17.

[0069] For example, in the second pipe 17, the cross-sectional shape in the direction perpendicular to the extending direction thereof is circular. In the second flow path 16, the cross-sectional shape in the direction perpendicular to the extending direction thereof is also circular.

[0070] The second flow path 16 has a descending portion 16a that extends from the branch point Pj and descends in the vertical direction Z as it moves toward the downstream side. As a result, the bubbles in the liquid in the first flow path 14 have a smaller specific gravity than the drug solution, and therefore, it is difficult for the bubbles to enter the descending portion 16a. As a result, when the drug solution flows from the first flow path 14 to the second flow path 16, it is possible to suppress the bubbles from being mixed into the drug solution, and it is possible to suppress the bubbles from being measured (counted) as particles by the measuring device 22. As a result, the measurement accuracy of the number of particles in the measuring device 22 can be improved.

[0071] In addition, the liquid medicine may contain particles, but the difference in specific gravity between the particles and the liquid medicine is not as great as the difference in specific gravity between the bubbles and the liquid medicine. Therefore, if the above structure is adopted, it has no effect on the measured number of particles, and the measurement accuracy of the number of particles in the measuring device 22 can be improved as described above.

[0072] Here, if Figure 2 As shown, in the first flow path 14, the flow path 14b adjacent to the branch point Pj on the upstream side of the branch point Pj and the flow path 14c adjacent to the branch point Pj on the downstream side of the branch point Pj in the first flow path 14 are arranged in a straight line. In addition, the flow path 14d adjacent to the confluence point Pc on the downstream side of the confluence point Pc is also arranged in a straight line with the above-mentioned flow path 14c.

[0073] As described above, in the structure where the flow paths 14b, 14c, and 14d are arranged in a straight line, it is possible to suppress the chemical liquid in the flow path from hitting the inner wall of the flow path, etc., compared with the structure where any of the flow paths 14b, 14c, and 14d are not arranged in a straight line, and as a result, it is difficult to generate bubbles in the chemical liquid. In addition, if the flow paths 14b, 14c, and 14d are arranged in a straight line, the flow path resistance becomes small, so that the chemical liquid is easy to flow in the first flow path, and the productivity of the chemical liquid for semiconductor manufacturing is improved.

[0074] In addition, the arrangement of flow paths 14b, flow paths 14c, and flow paths 14d on a straight line means that a straight line passing through the center of a cross section in a direction perpendicular to the direction in which flow path 14b extends in the extending direction, a straight line passing through the center of a cross section in a direction perpendicular to the direction in which flow path 14c extends in the extending direction, and a straight line passing through the center of a cross section in a direction perpendicular to the direction in which flow path 14d extends in the extending direction form a straight line.

[0075] In addition, in the first flow path 14, the cross-sectional area of ​​the flow path 14b adjacent to the branch point Pj on the upstream side of the branch point Pj in the first flow path 14 in the first flow path 14 in the first orthogonal direction Dc that is orthogonal to the extension direction DL of the first flow path 14 is the same as the cross-sectional area of ​​the flow path 14c adjacent to the branch point Pj on the downstream side of the branch point Pj in the first orthogonal direction Dc, and the cross-sectional area of ​​the flow path 14d in the first orthogonal direction Dc is also the same as the cross-sectional area of ​​the flow path 14b or the flow path 14c in the first orthogonal direction Dc.

[0076] As described above, the cross-sectional areas of flow paths 14b, 14c and 14d are the same, so that the flow path resistance is smaller than that of a flow path whose cross-sectional area is not constant but changes. Therefore, the chemical solution can easily flow in the first flow path 14, thereby improving the productivity of the chemical solution for semiconductor manufacturing.

[0077] In addition, the first piping 15 forming the first flow path 14 includes a first pipe 15b adjacent to the branch point Pj on the upstream side of the branch point Pj, a second pipe 15c adjacent to the branch point Pj on the downstream side of the branch point Pj, and a third pipe 15d adjacent to the confluence point Pc on the downstream side of the confluence point Pc.

[0078] The first tube 15b constitutes the flow path 14b, the second tube 15c constitutes the flow path 14c, and the third tube 15d constitutes the flow path 14d.

[0079] In addition, the first tube 15b, the second tube 15c, and the third tube 15d are arranged in a straight line. The first tube 15b, the second tube 15c, and the third tube 15d are arranged in a straight line in a state where a straight line passing through the center of a cross section in a direction perpendicular to the direction in which the first tube 15b extends in the extending direction, a straight line passing through the center of a cross section in a direction perpendicular to the direction in which the second tube 15c extends in the extending direction, and a straight line passing through the center of a cross section in a direction perpendicular to the direction in which the third tube 15d extends in the extending direction form a straight line.

[0080] In addition, among the first pipe 15 , the first pipe 15 b , the second pipe 15 c , and the third pipe 15 d , the cross-sectional areas in the first orthogonal direction Dc are the same.

[0081] As described above, the structure in which the first tube 15b, the second tube 15c, and the third tube 15d are arranged in a straight line is similar to the structure in which the flow paths 14b, the flow paths 14c, and the flow paths 14d are arranged in a straight line. Compared with the structure in which any of the first tube 15b, the second tube 15c, and the third tube 15d are not arranged in a straight line, bubbles are less likely to be generated in the chemical solution flowing in these tubes. In addition, if the structure in which the first tube 15b, the second tube 15c, and the third tube 15d are arranged in a straight line, the flow path resistance becomes small, so that the chemical solution is easy to flow in these tubes, and the productivity of the chemical solution for semiconductor manufacturing is improved.

[0082] In addition, as described above, the cross-sectional areas of the first tube 15b, the second tube 15c, and the third tube 15d in the first piping 15 are the same. Therefore, similar to the case where the cross-sectional areas of the flow paths 14b, 14c, and 14d are the same, the flow path resistance is smaller than that of a flow path whose cross-sectional area is not constant but changes. Therefore, the chemical solution is easy to flow in the first flow path, and the productivity of the chemical solution for semiconductor manufacturing is improved.

[0083] Figure 3 The arrangement of the first flow path 14 and the second flow path 16 is shown. That is, the arrangement of the first pipe 15 and the second pipe 17 is shown.

[0084] like Figure 3 As shown, the descending portion 16a of the second flow path 16 is arranged obliquely relative to the first flow path 14. With regard to the descending portion 16a of the second flow path 16, it is preferred that its extension direction Dm is arranged to be inclined at 45° or more relative to the horizontal plane H. Thus, it is possible to further suppress the mixing of bubbles into the liquid medicine in the second flow path 16. Therefore, it is possible to further improve the measurement accuracy of the number of particles in the measuring device 22, which is preferred. In addition, the extension direction Dm in which the descending portion 16a extends is the extension direction of the descending portion 16a.

[0085] More specifically, the center line C2 of the first pipe 17a of the second pipe 17 is arranged to be inclined with respect to the horizontal plane H passing through the center C of the first pipe 15. Figure 3 In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14 shown, it is preferable that the angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is 45° or more.

[0086] The angle θ is Figure 3 In the cross section on the first orthogonal direction Dc shown in FIG. 1 , the angle of the smaller of the two angles formed by the horizontal plane H and the center line C2 is used. In addition, when the angle is 90°, the angles of the above two angles are the same. In this case, the angle θ is set to 90°. Therefore, the upper limit value of the angle θ is 90°.

[0087] As for the rising portion 16b of the second flow path 16, similarly to the descending portion 16a described above, the rising portion 16b of the second flow path 16 is arranged to be inclined relative to the first flow path 14. It is preferred that the extending direction Dm in which the rising portion 16b of the second flow path 16 extends is inclined at 45° or more relative to the horizontal plane H. Thus, the liquid medicine in the second flow path 16 quickly moves to the first flow path 14. Thus, it is preferred that the liquid medicine is suppressed from being retained in the measuring device 22, and the measurement accuracy of the number of particles can be further improved.

[0088] More specifically, the center line of the second pipe 17b of the second pipe 17 is arranged to be inclined with respect to the horizontal plane H passing through the center C of the first pipe 15. Figure 3 In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14 shown, it is preferable that the angle of the center line of the second tube 17b with respect to the horizontal plane H is 45° or more.

[0089] In the rising portion 16b, the angle is similar to the descending portion 16a. Figure 3 In the cross section in the first orthogonal direction Dc shown, the smaller angle of the two angles formed by the horizontal plane H and the center line.

[0090] The second pipe 17 is provided, for example, with the center line C2 of the first pipe 17a and the center line C2 of the second pipe 17b being parallel. However, the present invention is not limited thereto, and the center line C2 of the first pipe 17a and the center line C2 of the second pipe 17b may not be parallel.

[0091] The descending portion 16 a of the second flow path 16 is configured to descend in the vertical direction Z toward the downstream side, that is, to be more distant from the horizontal plane H in the vertical direction Z toward the downstream side.

[0092] The rising portion 16 b of the second flow path 16 is configured to rise in the vertical direction Z toward the downstream side, that is, to approach the horizontal plane H in the vertical direction Z toward the downstream side.

[0093] The liquid ejector 18 is provided on the upstream side of the branch point Pj in the first flow channel 14 , and causes the liquid medicine in the liquid tank 12 to flow in the first flow channel 14 from the outflow end Pd toward the inflow end Pe.

[0094] The liquid ejector 18 is, for example, a pump. The pump is not particularly limited as long as it can make the liquid medicine in the liquid tank 12 flow into the first flow path 14 from the outflow end Pd toward the inflow end Pe. By using the liquid ejector 18 to make the liquid medicine flow in the first flow path 14, the liquid medicine also flows in the second flow path 16 via the branch point Pj of the first flow path 14. In addition, the liquid medicine flowing in the second flow path 16 merges with the liquid medicine flowing in the first flow path 14 at the confluence point Pc of the first flow path 14. As a result, the liquid medicine in the liquid tank 12 flows and circulates in the first flow path 14 and the second flow path 16. At this time, the liquid medicine passes through the filter 20 while flowing in the first flow path 14, thereby removing particles in the liquid medicine.

[0095] The operation of the liquid ejector 18 is controlled by the control unit 27 .

[0096] The filter 20 is disposed between the liquid ejector 18 and the branch point Pj in the first flow path 14. The filter 20 removes particles in the chemical solution.

[0097] The filter 20 has, for example, a pore size corresponding to the minimum size of the particles that can be removed. When the pore size of the filter 20 is 20 nm, particles with a diameter greater than 20 nm can be removed by the sieving effect. In addition, by depositing filter cakes on the filter 20 or by adsorption of particles to the filter 20, particles with a diameter of less than 20 nm can sometimes be removed.

[0098] The measuring device 22 is disposed in the second flow path 16 and counts the number of particles contained in the chemical solution in the second flow path 16. Specifically, the measuring device 22 is provided in the second pipe 17.

[0099] Data indicating a measured value of the number of particles contained in the chemical solution measured by the measuring device 22 is output to the control unit 27 .

[0100] The measuring device 22 is not particularly limited in structure as long as it can count the number of particles contained in the drug solution in the second flow channel 16 . For example, a light scattering type particle counter or a light shielding type particle counter can be used.

[0101] The liquid medicine flowing into the second flow path 16 from the branch point Pj in the first flow path 14 flows into the measuring device 22 from the liquid medicine inlet Pi of the measuring device 22 , flows out from the liquid medicine outlet Po of the measuring device 22 , and returns to the first flow path 14 from the confluence point Pc in the first flow path 14 .

[0102] The discharge flow path 24 is connected to the first flow path 14 via the valve 26 and is used to discharge the drug solution to the outside of the first flow path 14. The discharge flow path 24 has, for example, a straight portion 24a and a curved portion 24b curved relative to the straight portion 24a. The angle of the curved portion 24b relative to the straight portion 24a is, for example, 90°.

[0103] The discharge flow path 24 is constituted by, for example, a discharge pipe 25. The discharge flow path 24 is formed in the discharge pipe 25. The discharge pipe 25 has a straight pipe portion 25a and a bent pipe portion 25b bent relative to the straight pipe portion 25a, similarly to the discharge flow path 24. The angle of the bent pipe portion 25b relative to the straight pipe portion 25a is, for example, 90°.

[0104] The straight pipe portion 25a of the discharge pipe 25 is connected to the first pipe 15 via a valve 26. The bent pipe portion 25b of the discharge pipe 25 is connected to a container 28.

[0105] The valve 26 switches the flow path of the drug solution from the first flow path 14 to the discharge flow path 24. Specifically, the valve 26 is provided at one of the four bends 15e of the first pipe 15. The valve 26 is, for example, a three-way valve. The switching of the flow path of the drug solution by the valve 26 is controlled by the control unit 27.

[0106] Although a three-way valve is shown as the valve 26 , the valve is not particularly limited as long as the flow path of the chemical solution can be switched, and a two-way valve may be provided in each of the first pipe 15 and the discharge pipe 25 .

[0107] The container 28 is a component for storing the drug solution discharged from the discharge flow path 24. As described above, the bent pipe portion 25b of the discharge pipe 25 is connected to the container 28. The container 28 is made of a material corresponding to the composition of the drug solution, etc. In addition, the capacity of the container 28 is appropriately set according to the amount of the drug solution.

[0108] The control unit 27 is connected to the liquid ejector 18 , the measuring device 22 , and the valve 26 , and controls the liquid ejector 18 , the measuring device 22 , and the valve 26 .

[0109] Specifically, the control unit 27 operates the liquid ejector 18 to cause the liquid in the liquid tank 12 to flow into the first flow path 14 from the outflow end Pd toward the inflow end Pe, and stops the operation of the liquid ejector 18 .

[0110] Furthermore, the control unit 27 operates the valve 26 to switch the flow path of the chemical solution from the first flow path 14 to the discharge flow path 24 , and to switch the flow path of the chemical solution from the discharge flow path 24 to the first flow path 14 .

[0111] The control unit 27 stores a threshold value of the number of particles contained in the drug solution. In addition, data indicating the measured value of the number of particles of the measuring device 22 is received. In the control unit 27, the measurement result of the number of particles of the measuring device 22 is compared with the threshold value set for the number of particles contained in the drug solution. When the number of particles is less than the threshold value, the valve 26 is operated to switch the flow path of the drug solution from the first flow path 14 to the discharge flow path 24. Thus, the manufactured drug solution is filled into the container 28.

[0112] After the manufactured chemical solution is filled into the container 28 , the control unit 27 operates the valve 26 again to switch the flow path of the chemical solution from the discharge flow path 24 to the first flow path 14 .

[0113] The particle measuring device 10 for use in semiconductor manufacturing in a chemical solution further includes a raw material supply unit 29. The raw material supply unit 29 includes a first tank 30, a second tank 32, and a third tank 34, for example.

[0114] The first tank 30 and the liquid tank 12 are connected by a pipe 31 a. A pump 31 b and a valve 31 c are provided on the pipe 31 a in this order from the first tank 30 side. The first tank 30 stores a raw material liquid.

[0115] The second tank 32 and the liquid tank 12 are connected by a pipe 33a. A pump 33b and a valve 33c are provided on the pipe 33a in this order from the second tank 32 side. The second tank 32 stores the raw material liquid.

[0116] The third tank 34 and the liquid tank 12 are connected by a pipe 35a. A pump 35b and a valve 35c are provided on the pipe 35a in this order from the third tank 34 side. The third tank 34 stores a raw material liquid.

[0117] The raw material liquids stored in the first tank 30, the second tank 32, and the third tank 34 are one form of the raw material of the liquid medicine. The raw material liquid is a liquid obtained by mixing the raw material of the liquid medicine with a solvent (for example, water).

[0118] The chemical solution is obtained by mixing the raw material solutions from the first tank 30 , the second tank 32 , and the third tank 34 in the liquid tank 12 .

[0119] Although the structure is provided with the first tank 30, the second tank 32 and the third tank 34, for example, the liquid medicine is obtained by mixing two or more raw materials in a liquid tank, and therefore, at least two tanks for storing a raw material liquid in a form of the raw material are sufficient.

[0120] Alternatively, a raw material liquid itself may be used as a chemical liquid. In this case, at least one tank storing the raw material liquid may be sufficient.

[0121] The raw material supply unit 29 is not limited to the structure having the first tank 30 , the second tank 32 , and the third tank 34 , and the number of tanks and the like is appropriately determined according to the composition of the chemical solution.

[0122] Alternatively, a configuration without the raw material supply unit 29 may be adopted.

[0123] In addition, the above-mentioned pumps, valves, pipes, valves, liquid tanks, tanks, and containers can appropriately utilize those known in the relevant technical field.

[0124] Preferably, the cross-sectional area of ​​the first flow path 14 in the first orthogonal direction Dc orthogonal to the extension direction DL of the first flow path 14 is larger than the cross-sectional area of ​​the second flow path 16 in the second orthogonal direction Dn orthogonal to the extension direction Dm of the second flow path 16. Thus, the flow rate of the first flow path 14 can be greater than the flow rate of the second flow path 16.

[0125] The extending direction DL of the first flow path 14 is the extending direction of the first pipe 15. The cross-sectional area of ​​the first flow path 14 in the first orthogonal direction Dc is the area of ​​the region surrounded by the inner peripheral surface of the first pipe, that is, the area of ​​a circle having the inner diameter of the first pipe.

[0126] The extension direction Dm of the second flow path 16 is the extension direction of the second pipe 17. The cross-sectional area of ​​the second flow path 16 in the second orthogonal direction Dn is the area of ​​the region surrounded by the inner peripheral surface of the second pipe 17, that is, the area of ​​a circle having the inner diameter of the second pipe.

[0127] The cross-sectional area of ​​the first flow path 14 is preferably 30 to 8800 mm 2 .

[0128] The cross-sectional area of ​​the second flow path 16 is preferably 30 to 600 mm 2 .

[0129] In a device 10 for measuring particles in a liquid medicine for semiconductor manufacturing, a liquid medicine in a liquid tank 12 is discharged from an outflow end Pd by a liquid ejector 18 and flows into a first flow path 14, and is passed through a filter 20 and returned to an inflow end Pe of the liquid tank 12 via the first flow path 14 and the second flow path 16. At this time, the number of particles in the liquid medicine is measured by a measuring device 22. The liquid medicine is circulated in the first flow path 14 and the second flow path 16 until the number of particles is less than a predetermined number. Furthermore, when the number of particles is less than a predetermined number, the flow path of the liquid medicine is switched from the first flow path 14 to the discharge flow path 24 by a valve 26, and the container 28 is filled with the liquid medicine. Such an operation can obtain a liquid medicine for semiconductor manufacturing. The liquid medicine whose number of particles has been measured with high measurement accuracy can be filled into the container 28.

[0130] Second example of a device for measuring particles in a chemical solution for semiconductor manufacturing

[0131] Next, a second example of the device for measuring particles in a chemical solution used in semiconductor manufacturing will be described.

[0132] Figure 4 This is a schematic diagram showing a second example of the particle measuring device in a chemical solution used in semiconductor manufacturing according to an embodiment of the present invention. Figure 5 This is a schematic diagram showing the main part of a second example of the particle measuring device in a chemical solution used for semiconductor manufacturing according to an embodiment of the present invention. Figure 6 This is a schematic diagram showing the arrangement of the first flow path and the second flow path in the second example of the particle measuring apparatus in a chemical solution for semiconductor manufacturing according to the embodiment of the present invention.

[0133] In addition, Figures 4 to 6 In, with Figure 1 to Figure 3 The same components as shown are denoted by the same reference numerals, and detailed description thereof will be omitted.

[0134] exist Figure 4 The device 10a for measuring particles in a liquid used in semiconductor manufacturing is shown in FIG. Figure 1 Compared with the device 10 for measuring particles in a chemical solution for semiconductor manufacturing shown in FIG. 1 , the configuration structure of the second flow path 16 is different, and the other structures are the same as those of FIG. Figure 1 The device 10 for measuring particles in a liquid chemical used in semiconductor manufacturing is the same.

[0135] A device 10a for measuring particles in a liquid medicine for semiconductor manufacturing is provided. Figure 5 As shown in FIG. 1 , the extending direction of the descending portion 16a of the second flow path 16 is parallel to the direction inclined 90° relative to the horizontal plane H, that is, the vertical direction. Figure 6In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14 shown, the angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is 90°.

[0136] In addition, for example, the extending direction of the rising portion 16b of the second flow path 16 is parallel to the direction inclined 90° with respect to the horizontal plane H, that is, the vertical direction. Figure 6 In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14 shown, the angle θ of the center line of the second pipe 17b of the second pipe 17 with respect to the horizontal plane H passing through the center C of the first pipe 15 is also 90°.

[0137] As described above, when the angle θ is 90°, Figure 6 In the cross section along the first orthogonal direction Dc shown, the two angles formed by the horizontal plane H and the center line are the same.

[0138] By setting the extending direction of the descending portion 16a of the second flow path 16 to 90° with respect to the horizontal plane H, it is possible to further suppress the mixing of bubbles into the liquid medicine in the second flow path 16. Thus, the measurement accuracy of the number of particles in the measuring device 22 can be further improved.

[0139] The third example of the device for measuring particles in chemical liquid for semiconductor manufacturing

[0140] Next, a third example of the device for measuring particles in a chemical solution used in semiconductor manufacturing will be described.

[0141] Figure 7 This is a schematic diagram showing a third example of the particle measuring device in a chemical solution used in semiconductor manufacturing according to an embodiment of the present invention. Figure 8 This is a schematic diagram showing the main part of a third example of the particle measuring device in a chemical solution used for semiconductor manufacturing according to an embodiment of the present invention. Fig. 9 This is a schematic diagram showing a modification of the main part of the third example of the particle measuring device in a chemical solution for semiconductor manufacturing according to the embodiment of the present invention.

[0142] In addition, Figure 7 to Figure 9 In, with Figure 1 to Figure 3 The same components as shown are denoted by the same reference numerals, and detailed description thereof will be omitted.

[0143] exist Figure 7 In the device 10b for measuring particles in a liquid medicine for semiconductor manufacturing shown in FIG. Figure 1 Compared with the device 10 for measuring particles in a chemical solution for semiconductor manufacturing shown in FIG. 1 , the configuration structure of the second flow path 16 is different, and the other structures are the same as those of FIG. Figure 1The device 10 for measuring particles in a liquid chemical used in semiconductor manufacturing is the same.

[0144] In a device 10b for measuring particles in a liquid medicine for semiconductor manufacturing, as Figure 8 As shown, the second flow path 16 is provided in a linear flow path 14 f in which the extending direction DL is parallel to the vertical direction Z in the first flow path 14 .

[0145] In the particle measuring device 10b for semiconductor manufacturing, the confluence point Pc is located above the branch point Pj in the vertical direction Z, and the extension direction DL of the first flow path 14 at the branch point Pj is inclined at more than 85 degrees relative to the horizontal plane H.

[0146] In a device 10b for measuring particles in a liquid medicine for semiconductor manufacturing, as Figure 8 As shown, the angle β between the extending direction DL of the first flow channel 14 and the horizontal plane H passing through the branch point Pj is 90°. That is, the extending direction DL of the first flow channel 14 is inclined by 90° relative to the horizontal plane H at the branch point Pj.

[0147] The extension direction DL of the first flow path 14 is 90° relative to the horizontal plane H at the branch point Pj, so that the bubbles contained in the liquid medicine have a smaller specific gravity than the liquid medicine, and therefore at the branch point Pj, the bubbles are more likely to enter the first flow path 14 than the second flow path 16, and the number of bubbles from the second flow path 16 toward the measuring device 22 is reduced. As a result, the number of bubbles measured by the measuring device 22 is reduced, and the measurement accuracy of the number of particles contained in the liquid medicine can be further improved.

[0148] In the measuring device 10b for particles in a chemical solution for semiconductor manufacturing, similarly to the measuring device 10 for particles in a chemical solution for semiconductor manufacturing and the measuring device 10a for particles in a chemical solution for semiconductor manufacturing, the second flow path 16 has the descending portion 16a and the ascending portion 16b. Preferably, the extending direction of the descending portion 16a and the ascending portion 16b of the second flow path 16 is inclined at 45° or more relative to the horizontal plane H.

[0149] exist Figure 8 In the structure shown in FIG. 1 , it is preferred that the angle θ of the center line C2 of the first tube 17a relative to the horizontal plane H is 45° or more. In addition, it is preferred that the angle θ of the center line C2 of the second tube 17b relative to the horizontal plane H is 45° or more. Figure 8 In the illustrated structure, the first tube 17a and the second tube 17b of the second pipe 17 are arranged in parallel. However, the present invention is not limited thereto, and the extending direction of the first tube 17a may be inclined relative to the extending direction of the second tube 17b.

[0150] like Figure 7As shown, the above-mentioned device 10b for measuring particles in a liquid medicine for semiconductor manufacturing is configured such that, in the vertical direction Z, the confluence point Pc is located above the branch point Pj, and the extension direction DL of the first flow path 14 at the branch point Pj is inclined by more than 85° relative to the horizontal plane H, but the extension direction DL of the first flow path 14 extending from the branch point Pj relative to the horizontal plane H is as long as the angle α Fig. 9 That is, the extending direction DL of the first flow path 14 may be inclined at an angle of 45° or more relative to the horizontal plane H from the branch point Pj.

[0151] As described above, in the vertical direction Z, the confluence point Pc is located above the branch point Pj, and at the branch point Pj, the first flow path 14 is inclined by more than 45° relative to the horizontal plane H, so that the bubbles contained in the liquid medicine have a smaller specific gravity than the liquid medicine, and thus the bubbles are more likely to flow into the first flow path 14 than into the second flow path 16, and the number of bubbles heading toward the measuring device 22 is further reduced. This can further improve the measurement accuracy of the number of particles contained in the liquid medicine, and is therefore preferred.

[0152] The angles of the above-mentioned respective parts are obtained by measuring the position of the first pipe 15 forming the first flow path 14, the position and length of the first tube 17a corresponding to the descending portion 16a, and the position and length of the second tube 17b corresponding to the ascending portion 16b using a laser distance meter or a tape measure, and determining the positional relationship among the first pipe 15, the first tube 17a, and the second tube 17b. For example, the angles of the respective parts are obtained from the determined positional relationship, the length of the first tube 17a, and the length of the second tube 17b using a trigonometric function.

[0153] In addition, the angles of each portion can also be obtained based on the dimensions of a design drawing of a device for measuring particles in a chemical solution used in semiconductor manufacturing.

[0154] Filtration method for chemical liquid used in semiconductor manufacturing

[0155] The above-mentioned devices 10, 10a, and 10b for measuring particles in a chemical solution for semiconductor manufacturing are all configured with a filter 20 and can be used as devices for filtering chemical solutions.

[0156] The method for filtering a chemical solution for semiconductor manufacturing includes a step of filtering the chemical solution using the above-mentioned measuring apparatus 10 , 10 a , 10 b for particles in a chemical solution for semiconductor manufacturing.

[0157] In the method for filtering a chemical solution for semiconductor manufacturing, for example, the control unit 27 compares the measurement result of the number of particles of the measuring device 22 with a threshold value set for the number of particles contained in the chemical solution, and performs filtration of the chemical solution until the number of particles in the chemical solution is less than the threshold value. In this way, a chemical solution containing a number of particles less than the threshold value can be obtained.

[0158] Method for producing chemical solution for semiconductor manufacturing

[0159] The above-mentioned particle measuring apparatuses 10, 10a, 10b for chemical solution for semiconductor manufacturing can be used as an apparatus used in manufacturing chemical solution for semiconductor manufacturing.

[0160] The method for manufacturing a chemical solution for semiconductor manufacturing includes a step of mixing two or more raw materials to manufacture a chemical solution using the above-mentioned measuring device 10, 10a, 10b for measuring particles in a chemical solution for semiconductor manufacturing. In the manufacture of the chemical solution, for example, a raw material liquid can be used as described above, but the raw material itself of the chemical solution can also be used.

[0161] In the method for manufacturing a chemical solution for semiconductor manufacturing, for example, raw material solutions from the first tank 30, the second tank 32, and the third tank 34 are mixed in the liquid tank 12 to obtain a chemical solution. The mixed chemical solution is circulated in the first flow path 14 by the liquid ejector 18, and the chemical solution is circulated through the filter 20 until the number of particles in the chemical solution is less than a threshold value.

[0162] In the method for manufacturing a chemical solution for semiconductor manufacturing, for example, the control unit 27 compares the measurement result of the number of particles of the measuring device 22 with a threshold value set for the number of particles contained in the chemical solution, and when the number of particles in the chemical solution is less than the threshold value, the valve 26 is operated to switch the flow path of the chemical solution from the first flow path 14 to the discharge flow path 24, and the manufactured chemical solution is filled into the container 28. In this way, the chemical solution for semiconductor manufacturing can be manufactured.

[0163] Semiconductor substrate cleaning method

[0164] The chemical solution obtained by using the above-mentioned measuring device 10, 10a, 10b for measuring particles in chemical solution for semiconductor manufacturing can be used, for example, for cleaning semiconductor substrates. In this case, the composition of the chemical solution is made suitable for cleaning semiconductor substrates. The above-mentioned chemical solution is filled into a container 28 (see Figure 1 ). The chemical liquid in the container 28 is supplied as a cleaning liquid to the semiconductor substrate for cleaning. In addition to the semiconductor substrate, the chemical liquid can also be used as a cleaning liquid for semiconductor manufacturing equipment, for example.

[0165] Filters

[0166] As the material of the filter 20, for example, polyamides such as 6-nylon and 6,6-nylon, polyethylene, polypropylene, polystyrene, polyimide, polyamide-imide, and fluororesin can be cited. Polyimide and polyamide-imide can also be a material having at least one selected from the group consisting of a carboxyl group, a carboxyl group in the form of a salt, and an -NH- bond. Regarding solvent resistance, fluororesin, polyimide, and polyamide-imide are excellent. In addition, from the viewpoint of adsorbing metal ions, polyamides such as 6-nylon and 6,6-nylon are preferred, and nylon is more preferred.

[0167] The filter 20 may also be a structure having a metal ion adsorption filter and an organic impurity adsorption filter. As the metal ion adsorption filter, a filter capable of ion exchange is preferred. As the metal ion adsorption filter, for example, a polyimide and / or polyamide-imide porous membrane described in Japanese Patent Publication No. 2016-155121 may be cited.

[0168] The organic impurity adsorption filter is not particularly limited, and known organic impurity adsorption filters can be cited. Among them, as the organic impurity adsorption filter, from the viewpoint of improving the adsorption performance of organic impurities, it is preferred that the surface has an organic skeleton that can interact with the organic impurities (in other words, the surface is modified with an organic skeleton that can interact with the organic impurities). The organic impurity adsorption filter can also use a filter in which the activated carbon described in Japanese Patent Publication No. 2002-273123 and Japanese Patent Publication No. 2013-150979 is adhered and fixed on a non-woven fabric.

[0169] Semiconductor components

[0170] The semiconductor element is not particularly limited. More specifically, the semiconductor element includes, for example, a logic LSI (Large Scale Integration), an ASIC (Application Specific Integrated Circuit), an FPGA (Field Programmable Gate Array), an ASSP (Application Specific Standard Product), a microprocessor (for example, a CPU, a GPU, etc.), a memory (for example, a DRAM (Dynamic Random Access Memory), an SRAM (Static Random Access Memory), an HMC (Hybrid Memory Cube), an MRAM (Magnetic RAM), a PCM (Phase-Change Memory), a ReRAM (Resistive RAM), a FeRAM (Ferroelectric RAM), a flash memory, etc.), an LED (Light Emitting Diode), a power device, an analog IC (Integrated Circuit), for example, a DC (Direct Current)-DC (Direct Current) converter, an insulated gate bipolar transistor (IGBT), a MEMS (Micro Electro Mechanical Systems) such as an acceleration sensor, a pressure sensor, a vibrator, a gyro sensor, etc., for example, a GPS (Global Positioning System), an FM (Frequency Modulation), an NFC (Near Field Communication), an RFEM (RF Expansion Module), an MMIC (Monolithic Microwave Integrated Circuit), WLAN (Wireless Local Area Network), discrete components, BSI (Back Side Illumination), CIS (Contact Image Sensor), camera modules, passive devices, SAW (Surface Acoustic Wave) filters, RF (Radio Frequency) filters, RFIPD (Radio Frequency Integrated Passive Devices), BB (Broadband), etc.

[0171] The composition of the semiconductor constituting the semiconductor element is not particularly limited. Examples of the composition of the semiconductor include diamond, silicon (Si), germanium (Ge), silicon germanium (SiGe), silicon carbide (SiC), gallium arsenide (GaAs), gallium nitride (GaN), gallium oxide, and silicon on insulator (SOI).

[0172] Liquid

[0173] The chemical solution used in the device for measuring particles in chemical solution for semiconductor manufacturing of the present invention preferably contains water.

[0174] water

[0175] There is no particular limitation on the water as long as it does not affect the semiconductor substrate, and distilled water, ion-exchanged water, and pure water (ultrapure water) can be used. From the viewpoint of having less influence on the semiconductor substrate in the manufacturing process of the semiconductor element, pure water or ion-exchanged water is preferred.

[0176] The water content may be the remainder of the components that can be contained in the drug solution.

[0177] The content of water is preferably 50.0 to 99.99% by mass, more preferably 60.0 to 98.0% by mass, and even more preferably 65.0 to 85.0% by mass, relative to the total mass of the chemical solution.

[0178] Surfactants

[0179] From the viewpoint of achieving better cleaning performance, the chemical solution preferably contains a surfactant.

[0180] The surfactant is not particularly limited as long as it is a compound having a hydrophilic group and a hydrophobic group (lipophilic group) in one molecule, and examples thereof include nonionic surfactants and anionic surfactants.

[0181] Many surfactants have at least one hydrophobic group selected from the group consisting of an aliphatic hydrocarbon group, an aromatic hydrocarbon group, and a combination thereof.

[0182] The surfactant as a whole preferably has 16 to 100 carbon atoms.

[0183] Examples of the nonionic surfactant include ester-type nonionic surfactants, ether-type nonionic surfactants, and ester-ether-type nonionic surfactants, and ether-type nonionic surfactants are preferred.

[0184] As the nonionic surfactant, for example, the compounds exemplified in paragraph 0126 of International Publication No. 2022 / 044893 can also be cited, and the contents thereof are incorporated into the present specification.

[0185] Examples of the anionic surfactant include phosphate surfactants having a phosphate group, sulfonic acid surfactants having a sulfonic group, phosphonic acid surfactants having a phosphonic acid group, carboxylic acid surfactants having a carboxyl group, and sulfate surfactants having a sulfate group.

[0186] As the anionic surfactant, for example, the compounds exemplified in paragraphs 0116 to 0123 of International Publication No. 2022 / 044893 can also be cited, and the contents thereof are incorporated into the present specification.

[0187] The content of the surfactant is preferably 0.0001 to 1.0% by mass, more preferably 0.001 to 0.8% by mass, based on the total mass of the drug solution.

[0188] The surfactant may be used alone or in combination of two or more. When two or more surfactants are used, the total content is preferably within the above range.

[0189] Organic Acid

[0190] From the viewpoint of improving the removal performance of metal-containing substances, the chemical solution preferably contains an organic acid.

[0191] An organic acid is an organic compound having an acidic functional group and showing acidity in an aqueous solution (pH (hydrogen ion concentration) less than 7.0). Examples of the acidic functional group include a carboxyl group, a phosphonic acid group, a sulfonic acid group, a phenolic hydroxyl group, and a mercapto group.

[0192] In addition, in this specification, the compound which functions as the above-mentioned anionic surfactant is not included in the organic acid.

[0193] The organic acid is not particularly limited, and examples thereof include carboxylic acids having a carboxyl group in the molecule (organic carboxylic acids), phosphonic acids having a phosphonic acid group in the molecule (organic phosphonic acids), and sulfonic acids having a sulfonic group in the molecule (organic sulfonic acids). Carboxylic acids or phosphonic acids are preferred.

[0194] The number of functional groups possessed by the organic acid is not particularly limited, but is preferably 1 to 4, and more preferably 1 to 3.

[0195] In addition, from the viewpoint of better cleaning performance, the organic acid is preferably a compound having a function of chelating with the metal contained in the residue, and more preferably a compound having two or more functional groups (ligands) in the molecule that coordinate and bond with metal ions. As the ligand, the above-mentioned acidic functional groups can be cited, preferably a carboxylic acid group or a phosphonic acid group.

[0196] carboxylic acid

[0197] The carboxylic acid may be a monocarboxylic acid having one carboxyl group or a polycarboxylic acid having two or more carboxyl groups. From the viewpoint of better cleaning performance, a polycarboxylic acid having two or more (more preferably 2 to 4, and even more preferably 2 or 3) carboxyl groups is preferred.

[0198] Examples of the carboxylic acid include aminopolycarboxylic acids, amino acids, hydroxycarboxylic acids, and aliphatic carboxylic acids.

[0199] Aminopolycarboxylic acid

[0200] Aminopolycarboxylic acid is a compound having one or more amino groups and two or more carboxyl groups as ligands in the molecule.

[0201] Examples of the aminopolycarboxylic acid include aspartic acid, glutamic acid, butanediaminetetraacetic acid, diethylenetriaminepentaacetic acid (DTPA), ethylenediaminetetrapropionic acid, triethylenetetraaminehexaacetic acid, 1,3-diamino-2-hydroxypropane-N,N,N',N'-tetraacetic acid, propylenediaminetetraacetic acid, ethylenediaminetetraacetic acid (EDTA), trans-1,2-diaminocyclohexanetetraacetic acid (CyDTA), ethylenediaminediacetic acid, ethylenediaminedipropionic acid, 1,6-hexamethylene-diamine-N,N,N',N'-tetraacetic acid, N,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid, diaminopropanetetraacetic acid, 1,4,7,10-tetraazacyclododecane-tetraacetic acid, diaminopropanoltetraacetic acid, (hydroxyethyl)ethylenediaminetriacetic acid, and iminodiacetic acid (IDA).

[0202] Among them, DTPA, EDTA, CyDTA or IDA is preferred.

[0203] Amino Acids

[0204] Amino acids are compounds that have one carboxyl group and one or more amino groups in their molecules.

[0205] As amino acid, for example, glycine, serine, α-alanine (2-aminopropionic acid), β-alanine (3-aminopropionic acid), lysine, leucine, isoleucine, cystine, cysteine, methionine, ethionine, threonine, tryptophan, tyrosine, valine, histidine, histidine derivatives, asparagine, glutamine, arginine, proline, phenylalanine, the compounds described in paragraphs 0021 to 0023 of Japanese Patent Publication No. 2016-086094, and their salts. In addition, as histidine derivatives, compounds described in Japanese Patent Publication No. 2015-165561 and Japanese Patent Publication No. 2015-165562 can be cited, and their contents are introduced into this specification. In addition, as salt, alkali metal salts such as sodium salts and potassium salts, ammonium salts, carbonates, and acetates can be mentioned.

[0206] Among them, histidine, histidine derivatives, or sulfur-containing amino acids containing sulfur atoms are preferred, and histidine or sulfur-containing amino acids are more preferred. Examples of sulfur-containing amino acids include cystine, cysteine, ethionine, and methionine, and cystine or cysteine ​​is preferred.

[0207] Hydroxycarboxylic acid

[0208] Hydroxycarboxylic acids are compounds having one or more hydroxyl groups and one or more amino groups in the molecule.

[0209] Examples of the hydroxycarboxylic acid include malic acid, citric acid, glycolic acid, gluconic acid, heptanoic acid, tartaric acid and lactic acid. Gluconic acid, glycolic acid, malic acid, tartaric acid or citric acid is preferred, and gluconic acid or citric acid is more preferred.

[0210] Aliphatic carboxylic acid

[0211] Examples of the aliphatic carboxylic acid include oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, sebacic acid, and maleic acid. Adipic acid is preferred from the viewpoint of enhancing the effect of the present invention and the cleaning property.

[0212] Examples of carboxylic acids other than the above-mentioned aminopolycarboxylic acids, amino acids, hydroxycarboxylic acids, and aliphatic carboxylic acids include monocarboxylic acids.

[0213] Examples of the monocarboxylic acid include lower (having 1 to 4 carbon atoms) aliphatic monocarboxylic acids such as formic acid, acetic acid, propionic acid and butyric acid.

[0214] The carboxylic acid is preferably an amino acid, a hydroxycarboxylic acid or an aliphatic carboxylic acid, more preferably cystine, cysteine, histidine, gluconic acid, glycolic acid, malic acid, tartaric acid, citric acid or adipic acid, further preferably cysteine, gluconic acid, citric acid or adipic acid.

[0215] The carboxylic acids may be used alone or in combination of two or more.

[0216] The content of the carboxylic acid is not particularly limited, but is preferably 0.1 to 35.0% by mass, more preferably 1.0 to 35.0% by mass, based on the total mass of the drug solution.

[0217] Phosphonic acid

[0218] The phosphonic acid may be a monophosphonic acid having one phosphonic acid group or a polyphosphonic acid having two or more phosphonic acid groups. From the viewpoint of better cleaning performance, a polyphosphonic acid having two or more phosphonic acid groups is preferred.

[0219] As the polyphosphonic acid, the substances represented by the general formulas 1 to 3 described in paragraphs 0013 to 0023 of the specification of International Publication No. 2013 / 162020, the substances described in paragraphs 0026 to 0036 of the specification of International Publication No. 2018 / 020878, and the compounds ((co)polymers) described in paragraphs 0031 to 0046 of the specification of International Publication No. 2018 / 030006 can be cited, and their contents are incorporated into the present specification.

[0220] Examples of the polyphosphonic acid include ethylenediphosphonic acid, 1-hydroxyethylidene-1,1'-diphosphonic acid (HEDPO), 1-hydroxypropylene-1,1'-diphosphonic acid, 1-hydroxybutylene-1,1'-diphosphonic acid, ethylaminobis(methylenephosphonic acid), dodecylaminobis(methylenephosphonic acid), nitrilotri(methylenephosphonic acid) (NTPO), ethylenediaminebis(methylenephosphonic acid) (EDDPO), 1,3-propylenediaminebis(methylenephosphonic acid), ethylenediaminetetra( 1,3-propylenediaminetetrakis(methylenephosphonic acid) (PDTMP), 1,2-diaminopropanetetrakis(methylenephosphonic acid), 1,6-hexamethylenediaminetetrakis(methylenephosphonic acid), diethylenetriaminepenta(methylenephosphonic acid) (DEPPO), diethylenetriaminepenta(ethylenephosphonic acid), triethylenetetraaminehexa(methylenephosphonic acid) and triethylenetetraaminehexa(ethylenephosphonic acid), preferably HEDPO.

[0221] The number of phosphonic acid groups contained in phosphonic acid is preferably 2 to 5, more preferably 2 to 4, and even more preferably 2 or 3.

[0222] The number of carbon atoms in the phosphonic acid is preferably 12 or less, more preferably 10 or less, and even more preferably 8 or less. The lower limit is not particularly limited, but is preferably 1 or more.

[0223] The phosphonic acid may be used alone or in combination of two or more.

[0224] The content of phosphonic acid is not particularly limited, but is preferably 0.001 to 5.0% by mass, more preferably 0.01 to 2.0% by mass, based on the total mass of the chemical solution.

[0225] The organic acid preferably has a low molecular weight. More specifically, the molecular weight of the organic acid is preferably 600 or less, more preferably 450 or less, and further preferably 300 or less. The lower limit is not particularly limited, but is preferably 85 or more.

[0226] The number of carbon atoms in the organic acid is preferably 15 or less, more preferably 12 or less, and even more preferably 8 or less. The lower limit is not particularly limited, but is preferably 1 or more.

[0227] The organic acid may be used alone or in combination of two or more.

[0228] The content of the organic acid is not particularly limited, but is preferably 0.1 to 40% by mass, more preferably 1.0 to 35% by mass, based on the total mass of the drug solution.

[0229] From the viewpoint of achieving better cleaning performance, the chemical solution preferably contains carboxylic acid and phosphonic acid.

[0230] Other Ingredients

[0231] The drug solution may contain components other than those described above (hereinafter also referred to as “other components”).

[0232] Other components include pH adjusters (e.g., alkaline compounds and acidic compounds), organic solvents (e.g., alcohol solvents, glycol solvents, glycol ether solvents, and ketone solvents), water-soluble polymers (e.g., water-soluble polymers described in paragraphs

[0043] to

[0047] of JP-A-2016-171294), and oxidizing agents (e.g., peroxides, persulfides, and percarbonates, their acids, and their salts).

[0233] Physical properties of the drug solution

[0234] The properties of the drug solution are described in detail below.

[0235] pH

[0236] The drug solution may be either alkaline or acidic.

[0237] The pH of the drug solution is preferably 0.10 to 4.00.

[0238] The pH of the drug solution can be adjusted using the above-mentioned pH adjuster.

[0239] The pH of the chemical solution can be measured using a known pH meter by a method in accordance with JIS (Japanese Industrial Standards) Z8802-1984. The measurement temperature is set at 25°C.

[0240] Metal content

[0241] The content (measured as ion concentration) of metals (e.g., metal elements such as Fe, Co, Na, Cu, Mg, Mn, Li, Al, Cr, Ni, Zn, Sn, and Ag) contained as impurities in the chemical solution is preferably 5 mass ppm or less, and more preferably 1 mass ppm or less. In the manufacture of the most advanced semiconductor elements, since a chemical solution with a higher purity is assumed to be required, the metal content is further preferably a value lower than 1 mass ppm, that is, a mass ppb level or less, particularly preferably 100 mass ppb or less, and most preferably less than 10 mass ppb. As the lower limit, 0 is preferred.

[0242] Examples of methods for reducing the metal content include purification treatment such as distillation or filtration using an ion exchange resin or a filter at the stage of the raw material (eg, raw material solution) used in the production of the chemical solution or after the production of the chemical solution.

[0243] As another method of reducing the metal content, it is possible to use a container with less impurity dissolution as described below as a container for storing raw materials or manufactured liquid medicine. In addition, in order to prevent the metal component from dissolving from the piping, etc. when manufacturing the liquid medicine, it is also possible to line the inner wall of the piping with fluororesin.

[0244] Coarse particles

[0245] The drug solution may contain coarse particles, but the content thereof is preferably low.

[0246] The coarse particles are particles having a diameter (particle size) of 0.03 μm or more when the particle shape is regarded as a sphere.

[0247] The coarse particles contained in the drug solution refer to particles of dust, dirt, organic solids, inorganic solids, etc. contained as impurities in the raw materials, as well as particles of dust, dirt, organic solids, inorganic solids, etc. brought in as contaminants during the preparation of the drug solution. They are equivalent to substances that ultimately do not dissolve in the drug solution and exist as particles.

[0248] The content of coarse particles in the drug solution is preferably 10,000 or less, more preferably 5,000 or less, per 1 mL of the drug solution. The lower limit is preferably 0 or more, more preferably 0.01 or more, per 1 mL of the drug solution.

[0249] The content of coarse particles present in the drug solution can be measured in a liquid phase using a commercially available measuring device of a light scattering liquid particle measuring method using laser light as a light source.

[0250] As a method for removing coarse particles, for example, purification treatment such as filtration is mentioned.

[0251] Method for producing liquid medicine

[0252] The chemical solution used in the device for measuring particles in chemical solution for semiconductor manufacturing of the present invention can be produced by a known method. Hereinafter, the method for producing the chemical solution used in the device for measuring particles in chemical solution for semiconductor manufacturing of the present invention will be described in detail.

[0253] Liquid adjustment process

[0254] The drug solution can be produced by mixing the above-mentioned components, for example.

[0255] As a method for preparing the liquid medicine, for example, the following method can be mentioned: after adding the above-mentioned components in a container containing purified pure water, stirring and mixing, and adding a pH adjuster as needed to adjust the pH of the mixed solution, thereby preparing the liquid medicine. In addition, when adding water and each component to the container, they can be added all at once or in multiple times.

[0256] The stirring device and stirring method used in the preparation of the liquid medicine can be any known device as a stirrer or a disperser. Examples of stirrers include industrial mixers, portable stirrers, mechanical stirrers, and magnetic stirrers. Examples of dispersers include industrial dispersers, homogenizers, ultrasonic dispersers, and bead mills.

[0257] The liquid medicine stored in the liquid tank of the device for measuring particles in liquid medicine for semiconductor manufacturing of the present invention may be a liquid medicine obtained by mixing two or more raw material liquids in the liquid tank. That is, the liquid medicine used in the device for measuring particles in liquid medicine for semiconductor manufacturing of the present invention may be a liquid medicine prepared in the liquid tank.

[0258] The two or more raw material solutions preferably contain components different from each other.

[0259] Specific examples of the raw material liquid include a liquid containing at least one selected from the group consisting of the above-mentioned surfactant, organic acid and other components and water.

[0260] refined

[0261] It is preferred that at least one of the raw materials used for preparing the drug solution be subjected to a purification treatment in advance. Examples of the purification treatment include known methods such as distillation, ion exchange, and filtering.

[0262] The degree of purification is preferably such that the purity of the raw material is 99% by mass or more, more preferably such that the purity of the raw material is 99.9% by mass or more, and the upper limit is preferably 99.9999% by mass or less.

[0263] Examples of the purification method include a method of passing the raw material through an ion exchange resin or an RO membrane (Reverse Osmosis Membrane), distillation of the raw material, and filtration described below.

[0264] As a purification treatment, a plurality of the above-mentioned purification methods may be combined and implemented. For example, the raw material may be purified once by passing it through an RO membrane and then purified twice by passing it through a purification device composed of a cation exchange resin, an anion exchange resin or a mixed bed type ion exchange resin.

[0265] Furthermore, the purification treatment may be performed multiple times.

[0266] As a filter for filtering, there is no particular limitation as long as it is a filter that has been used for filtering purposes. For example, filters composed of fluororesins such as polytetrafluoroethylene (PTFE) and tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA), polyamide resins such as nylon, and polyolefins such as polyethylene and polypropylene (PP) (including high-density or ultra-high molecular weight) can be cited. Among these materials, it is preferred to select materials from the group consisting of polyethylene, polypropylene (including high-density polypropylene), fluororesins (including PTFE and PFA), and polyamide resins (including nylon), and fluororesin filters are more preferred. By using filters formed from these materials to filter raw materials, foreign matter with high polarity that is likely to cause defects can be effectively removed.

[0267] Uses of liquid medicine

[0268] The chemical solution used in the measuring device of the present invention is preferably used as a cleaning solution, and more preferably used as a cleaning solution used for cleaning performed after a chemical mechanical polishing (CMP) process.

[0269] When the chemical liquid is used as the cleaning liquid, the object to be cleaned is preferably a semiconductor substrate, and more preferably a semiconductor substrate subjected to a CMP process.

[0270] The present invention is basically constructed as described above. The measuring device, filtering method, manufacturing method and production device for particles in a chemical solution for semiconductor manufacturing of the present invention are described in detail above, but the present invention is not limited to the above-mentioned embodiments, and various improvements or changes can be made without departing from the scope of the present invention.

[0271] Example

[0272] The following examples are given to illustrate the features of the present invention in more detail. As long as they do not depart from the gist of the present invention, the materials, reagents, amounts and ratios thereof, and operations shown in the following examples may be appropriately changed. Therefore, the scope of the present invention is not limited to the following specific example interpretation.

[0273] In this example, the number of particles was measured for Examples 1 to 5 and Comparative Examples 1 to 3. The results are shown in Table 2 below. The measured values ​​of the number of particles are based on Comparative Example 2. Regarding the measured values ​​of the number of particles, the number of particles in Comparative Example 2 is set to 1.00, and the number of particles in Examples 1 to 5 and Comparative Examples 1 and 2 are expressed as relative values.

[0274] Number of particles

[0275] The number of particles was measured using UltraChem (registered trademark) 40 manufactured by Yamato Scientific Co., Ltd. as a measuring instrument.

[0276] Liquid

[0277] In the present example and comparative example, the following chemical solution 1 was used.

[0278] Preparation of liquid medicine

[0279] Citric acid, 1-hydroxyethylidene-1,1'-diphosphonic acid (hereinafter also referred to as "HEDPO"), a sulfonic acid surfactant and water were added to a liquid tank in an apparatus used in each of the following Examples and Comparative Examples according to the contents shown in Table 1 and mixed to obtain a chemical solution 1.

[0280] Here, the sulfonic acid surfactants were mixed with each surfactant (LAS-10 to LAS-14) at the ratio shown in the "Ratio" column of Table 1, and mixed so as to have the content (0.01% by mass) shown in Table 1. In addition, the "Ratio" column shows the content (% by mass) of each surfactant (LAS-10 to LAS-14) relative to the total mass of the sulfonic acid surfactants.

[0281] Element

[0282] The components used for preparing the drug solution 1 are shown below.

[0283] Citric acid

[0284] 30 mass% citric acid aqueous solution

[0285] The citric acid content shown in Table 1 is the content of citric acid itself relative to the total mass of the chemical solution 1, and water in the aqueous solution is not included in the citric acid content.

[0286] HEDPO

[0287] 60 mass% 1-hydroxyethylidene-1,1'-diphosphonic acid aqueous solution

[0288] The HEDPO content shown in Table 1 is the content of HEDPO itself relative to the total mass of the chemical solution 1, and water in the aqueous solution is not included in the HEDPO content.

[0289] Sulfonic acid surfactant

[0290] LAS-10: Sulfonic acid A

[0291] LAS-11: Sulfonic acid B

[0292] LAS-12: Sulfonic acid C

[0293] LAS-13: Sulfonic acid D

[0294] Chemical formula 1

[0295]

[0296] water

[0297] Ultrapure water

[0298] Table 1

[0299]

[0300] Hereinafter, Examples 1 to 5 and Comparative Examples 1 to 3 will be described.

[0301] In Examples 1 to 5 and Comparative Examples 1 to 3, a circulation operation is implemented in which the liquid 1 obtained by mixing raw materials in the liquid tank of each device is ejected from the outflow end through the liquid ejector and returned to the inflow end of the liquid tank, and the circulation is continued until the number of particles in the measuring device reaches a constant.

[0302] In Examples 1 to 5 and Comparative Examples 1 to 3, the flow rate of the chemical solution in the first flow path by the liquid ejector was set to 8 L / min. The first flow path was formed using a round tube with an inner diameter of 28 mm. The second flow path was formed using a round tube with an inner diameter of 16 mm.

[0303] As the filter, a 1.2 μm polypropylene (model: PG12020T1, manufactured by Entergris) was used.

[0304] In Example 1, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Figure 2 In the first embodiment, the direction in which the first flow path (first pipe) extends is parallel to the horizontal plane H.

[0305] In Example 1, Figure 3 In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14, the angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is set to 10°. That is, in Example 1, the inclination angle of the descending portion 16a with respect to the horizontal plane H is set to 10°.

[0306] In Example 2, the configurations of the first flow path (first piping), the second flow path (second piping) and the measuring device are the same as those in Example 1. Figure 2 In the second embodiment, the direction in which the first flow path (first pipe) extends is parallel to the horizontal plane H.

[0307] In Example 2, Figure 3 In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14, the angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is set to 45°. That is, in Example 2, the inclination angle of the descending portion 16a with respect to the horizontal plane H is set to 45°.

[0308] In Example 3, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Figure 5 Configuration shown.

[0309] In Example 3, Figure 6 In the cross section in the first orthogonal direction Dc orthogonal to the extending direction DL of the first flow path 14, the angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is set to 90°. That is, in Example 3, the inclination angle of the descending portion 16a with respect to the horizontal plane H is set to 90°.

[0310] In Example 4, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Figure 8 Configuration shown.

[0311] In Example 4, Figure 8 The angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is set to 10°, and the angle θ of the center line C2 of the second tube 17b with respect to the horizontal plane H is set to 10°. The first tube 17a and the second tube 17b are arranged in parallel. That is, in Example 4, the inclination angle of each of the descending portion 16a and the ascending portion 16b with respect to the horizontal plane H is set to 10°.

[0312] In Example 5, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Figure 8 Configuration shown.

[0313] In Example 5, Figure 8 The angle θ of the center line C2 of the first tube 17a with respect to the horizontal plane H is set to 45°, and the angle θ of the center line C2 of the second tube 17b with respect to the horizontal plane H is set to 45°. The first tube 17a and the second tube 17b are arranged in parallel. That is, in Example 5, the inclination angle of each of the descending portion 16a and the ascending portion 16b with respect to the horizontal plane H is set to 45°.

[0314] In Comparative Example 1, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Fig.10 Configuration shown.

[0315] Here, Fig.10 Schematic diagram showing the configuration of the first flow path and the second flow path in Comparative Example 1. Fig.10 In, with Figure 1 to Figure 3 The same components are denoted by the same reference numerals, and detailed description thereof will be omitted.

[0316] like Fig.10 As shown, Comparative Example 1 is a structure in which there is no descending portion in the second flow path 16. The second flow path 16 is arranged on the upper side in the vertical direction Z with respect to the horizontal plane H.

[0317] In Comparative Example 2, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Fig.11 Configuration shown.

[0318] Here, Fig.11 Schematic diagram showing the configuration of the first flow path and the second flow path in Comparative Example 2. Fig.11 In, with Figure 1 to Figure 3 The same components are denoted by the same reference numerals, and detailed description thereof will be omitted.

[0319] like Fig.11 As shown, Comparative Example 2 is a structure in which there is no descending portion in the second flow path 16. The second flow path 16 is arranged on the horizontal plane H.

[0320] In Comparative Example 3, the first flow path (first pipe), the second flow path (second pipe) and the measuring device are arranged as follows: Fig.12 Configuration shown.

[0321] Here, Fig.12 Schematic diagram showing the configuration of the first flow path and the second flow path in Comparative Example 3. Fig.12 In, with Figure 1 to Figure 3 The same components are denoted by the same reference numerals, and detailed description thereof will be omitted.

[0322] like Fig.12 As shown, in Comparative Example 3, similarly to Example 5, the extending direction DL of the first flow path 14 extends at 90° relative to the horizontal plane H.

[0323] Comparative Example 3 has no descending portion in the second flow path 16. The first pipe 17a and the second pipe 17b of the second pipe 17 forming the second flow path 16 extend in the first orthogonal direction Dc of the first flow path 14. The extending direction Dm of the second flow path 16 is parallel to the horizontal plane H.

[0324] Table 2

[0325]

[0326] In Table 2, the smaller the measured value of the number of particles, the smaller the number of particles measured. As shown in Table 2, the measured values ​​of the number of particles in Examples 1 to 5 are smaller than those in Comparative Examples 1 to 3. It is believed that this is because, by providing a descending portion extending from the branch point and descending in the vertical direction toward the downstream side, the entry of bubbles into the second flow path is effectively suppressed, and the bubbles contained in the liquid medicine measured by the measuring device are reduced, so that the measurement result is close to the correct value (the actual number of particles).

[0327] According to Examples 1 to 3, the larger the inclination angle of the descending portion, the smaller the measured value of the number of particles. This indicates that increasing the inclination angle of the descending portion can more effectively suppress the entry of bubbles into the second flow path.

[0328] According to Examples 4 and 5, it can be seen that the larger the inclination angle of the descending portion, the smaller the measured value of the number of particles. This indicates that by increasing the inclination angle of the descending portion, the entry of bubbles into the second flow path is more effectively suppressed.

[0329] In addition, by comparing Example 1 and Example 4, it can be seen that Example 4 in which the second flow path is provided in the first flow path extending in the vertical direction can more effectively suppress the entry of bubbles into the second flow path and can make the measured value of the number of particles closer to the correct value.

[0330] In addition, by comparing Example 2 and Example 5, it can be seen that Example 5 in which the second flow path is provided in the first flow path extending in the vertical direction can more effectively suppress the entry of bubbles into the second flow path, and can make the measured value of the number of particles closer to the correct value.

[0331] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A device for measuring particles in liquid medicine used in semiconductor manufacturing, It is characterized in that include: A liquid tank for storing chemical solutions used in semiconductor manufacturing, The liquid tank has an outflow end for the liquid medicine to flow out of the liquid tank and an inflow end for the liquid medicine to flow into the liquid tank; A first flow path connecting the outflow end and the inflow end for the liquid medicine to flow; a second flow path extending from a branch point in the first flow path to a confluence point in the first flow path located downstream of the branch point; a liquid ejector disposed in the first flow path on the upstream side of the branch point and causing the liquid medicine in the liquid tank to flow into the first flow path; a filter disposed between the liquid ejector and the branch point in the first flow path; and a measuring device disposed in the second flow path and configured to count the number of particles contained in the drug solution in the second flow path; The second flow path includes a descending portion extending from the branch point and descending in the vertical direction toward the downstream side thereof. In the first flow path, a flow path adjacent to the branch point on the upstream side of the branch point and a flow path adjacent to the branch point on the downstream side of the branch point are arranged in a straight line, In the first flow path, the cross-sectional area of ​​the flow path adjacent to the branch point on the upstream side of the branch point in a first orthogonal direction perpendicular to the direction in which the first flow path extends is the same as the cross-sectional area of ​​the flow path adjacent to the branch point on the downstream side of the branch point in the first orthogonal direction.

2. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: In the first flow path, the cross-sectional area of ​​the flow path adjacent to the branch point on the upstream side of the branch point in the first orthogonal direction and the cross-sectional area of ​​the flow path adjacent to the branch point on the downstream side of the branch point in the first orthogonal direction are larger than the cross-sectional area of ​​the second flow path in the second orthogonal direction orthogonal to the direction in which the second flow path extends.

3. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: In the first flow path, a cross-sectional area in the first orthogonal direction is constant in a range from the flow path adjacent to the branch point on the upstream side of the branch point to the flow path adjacent to the confluence point on the downstream side of the confluence point.

4. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: The extending direction of the descending portion is inclined at more than 45 degrees relative to the horizontal plane.

5. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: In the vertical direction, the confluence point is located above the branch point, and the direction in which the first flow path extends is inclined at 45° or more from the branch point with respect to a horizontal plane.

6. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 5, Features: The direction in which the first flow path extends is inclined at an angle of more than 85° relative to a horizontal plane from the branch point.

7. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: The second flow path is provided with a rising portion that extends toward the merging point to the merging point and rises in the vertical direction toward the downstream side.

8. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 7, Features: The extending direction of the rising portion is inclined at more than 45 degrees relative to the horizontal plane.

9. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: The liquid medicine is a cleaning liquid.

10. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 9, Features: The chemical solution is a cleaning solution used for cleaning performed after the chemical mechanical polishing process.

11. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: The drug solution contains carboxylic acid and phosphonic acid.

12. A device for measuring particles in a liquid medicine for semiconductor manufacturing as claimed in claim 1, Features: The chemical solution is obtained by mixing two or more raw materials in the liquid tank.

13. An apparatus for producing a chemical solution for semiconductor manufacturing, It is characterized in that The method comprises a measuring device as claimed in any one of claims 1 to 12.

14. A method for filtering a chemical solution for semiconductor manufacturing, It is characterized in that The method comprises the step of filtering the drug solution using the measuring device according to any one of claims 1 to 12.

15. A method for producing a chemical solution for semiconductor manufacturing, It is characterized in that The method comprises the step of mixing two or more raw materials using the measuring device according to any one of claims 1 to 12 to produce the drug solution.

Citation Information

Patent Citations

  • Compound having laminar structure of hexagonal crystal system expressed by ingazn4o7 and its production

    JP1988210023A

  • Apparatus for detecting fine particle in liquid and processing apparatus

    JP1997005228A

  • Chemical filter

    JP2002273123A

  • Filters employing both acidic polymers and physical-adsorption media

    JP2013150979A

  • Substrate cleaning liquid for semiconductor devices and method for cleaning substrate for semiconductor devices

    JP2015165561A